ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Infectious Disease Point of Care Diagnostics Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-4Q2999
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Infectious Disease Point of Care Diagnostics Market Insights Forecast to 2028
BUY CHAPTERS

Global Infectious Disease Point of Care Diagnostics Market Research Report 2024

Code: QYRE-Auto-4Q2999
Report
February 2024
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott
Siemens AG
GE Healthcare
Accriva
Terumo
Biomerieux
DiaSorin
Roche
Danaher Corporation
BD
Bio Rad Laboratories
Cavidi
Cepheid Inc
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
EUROIMMUN
Gold Standard Diagnostics
Hologic Inc
Immunetics
InBios International

Infectious Disease Point of Care Diagnostics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Infectious Disease Point of Care Diagnostics Market

Infectious Disease Point of Care Diagnostics Market

Point-of-care diagnosis is a test performed on the site of patient care that provides immediate results.Infectious diseases are caused by various microorganisms, such as viruses, bacteria, fungi and parasites.Instant diagnosis of infectious diseases can improve disease management and detection, reducing the time between disease testing and diagnosis of infection.It also reduces postoperative care time, improves outcomes, improves accuracy of outcomes, and provides a simple way to diagnose infectious diseases, broadly reducing the risk of HIV, tuberculosis, influenza, tropical diseases, and sexually transmitted infections.
The global Infectious Disease Point of Care Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infectious Disease Point of Care Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Point of Care Diagnostics.

Report Scope

The Infectious Disease Point of Care Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Disease Point of Care Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Disease Point of Care Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Infectious Disease Point of Care Diagnostics Market Report

Report Metric Details
Report Name Infectious Disease Point of Care Diagnostics Market
CAGR 5%
Segment by Type
  • Over-the-counter (OTC) Testing Kits
  • Prescription-based Testing Kits
Segment by Application
  • Bacterial Infections
  • Fungal Infection
  • Virus Infection
  • Cardiovascular Infection
  • Gastrointestinal Infection
  • Sexually Transmitted Disease (STD) Infection
  • Central Nervous System Infection
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, Siemens, GE Healthcare, Accriva, Terumo, BioMerieux, Diasorin, Roche, Danaher Corporation, BD, Bio-Rad Laboratories, Cavidi, Cepheid, Diaxonhit, Eiken Chemical, EMD Millipore, Epitope Diagnostic, Euroimmun, Gold Standard Diagnostics, Hologic, Immunetics, InBios International
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Infectious Disease Point of Care Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Infectious Disease Point of Care Diagnostics Market report?

Ans: The main players in the Infectious Disease Point of Care Diagnostics Market are Abbott, Siemens, GE Healthcare, Accriva, Terumo, BioMerieux, Diasorin, Roche, Danaher Corporation, BD, Bio-Rad Laboratories, Cavidi, Cepheid, Diaxonhit, Eiken Chemical, EMD Millipore, Epitope Diagnostic, Euroimmun, Gold Standard Diagnostics, Hologic, Immunetics, InBios International

What are the Application segmentation covered in the Infectious Disease Point of Care Diagnostics Market report?

Ans: The Applications covered in the Infectious Disease Point of Care Diagnostics Market report are Bacterial Infections, Fungal Infection, Virus Infection, Cardiovascular Infection, Gastrointestinal Infection, Sexually Transmitted Disease (STD) Infection, Central Nervous System Infection, Other

What are the Type segmentation covered in the Infectious Disease Point of Care Diagnostics Market report?

Ans: The Types covered in the Infectious Disease Point of Care Diagnostics Market report are Over-the-counter (OTC) Testing Kits, Prescription-based Testing Kits

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Over-the-counter (OTC) Testing Kits
1.2.3 Prescription-based Testing Kits
1.3 Market by Application
1.3.1 Global Infectious Disease Point of Care Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Bacterial Infections
1.3.3 Fungal Infection
1.3.4 Virus Infection
1.3.5 Cardiovascular Infection
1.3.6 Gastrointestinal Infection
1.3.7 Sexually Transmitted Disease (STD) Infection
1.3.8 Central Nervous System Infection
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Point of Care Diagnostics Market Perspective (2019-2030)
2.2 Infectious Disease Point of Care Diagnostics Growth Trends by Region
2.2.1 Global Infectious Disease Point of Care Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Infectious Disease Point of Care Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Infectious Disease Point of Care Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Infectious Disease Point of Care Diagnostics Market Dynamics
2.3.1 Infectious Disease Point of Care Diagnostics Industry Trends
2.3.2 Infectious Disease Point of Care Diagnostics Market Drivers
2.3.3 Infectious Disease Point of Care Diagnostics Market Challenges
2.3.4 Infectious Disease Point of Care Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Point of Care Diagnostics Players by Revenue
3.1.1 Global Top Infectious Disease Point of Care Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Infectious Disease Point of Care Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Point of Care Diagnostics Revenue
3.4 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio
3.4.1 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Point of Care Diagnostics Revenue in 2023
3.5 Infectious Disease Point of Care Diagnostics Key Players Head office and Area Served
3.6 Key Players Infectious Disease Point of Care Diagnostics Product Solution and Service
3.7 Date of Enter into Infectious Disease Point of Care Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Point of Care Diagnostics Breakdown Data by Type
4.1 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Type (2025-2030)
5 Infectious Disease Point of Care Diagnostics Breakdown Data by Application
5.1 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Infectious Disease Point of Care Diagnostics Market Size (2019-2030)
6.2 North America Infectious Disease Point of Care Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Infectious Disease Point of Care Diagnostics Market Size by Country (2019-2024)
6.4 North America Infectious Disease Point of Care Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Disease Point of Care Diagnostics Market Size (2019-2030)
7.2 Europe Infectious Disease Point of Care Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2019-2024)
7.4 Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Disease Point of Care Diagnostics Market Size (2019-2030)
9.2 Latin America Infectious Disease Point of Care Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Infectious Disease Point of Care Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Infectious Disease Point of Care Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Infectious Disease Point of Care Diagnostics Introduction
11.1.4 Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Siemens
11.2.1 Siemens Company Detail
11.2.2 Siemens Business Overview
11.2.3 Siemens Infectious Disease Point of Care Diagnostics Introduction
11.2.4 Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.2.5 Siemens Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Detail
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Infectious Disease Point of Care Diagnostics Introduction
11.3.4 GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.3.5 GE Healthcare Recent Development
11.4 Accriva
11.4.1 Accriva Company Detail
11.4.2 Accriva Business Overview
11.4.3 Accriva Infectious Disease Point of Care Diagnostics Introduction
11.4.4 Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.4.5 Accriva Recent Development
11.5 Terumo
11.5.1 Terumo Company Detail
11.5.2 Terumo Business Overview
11.5.3 Terumo Infectious Disease Point of Care Diagnostics Introduction
11.5.4 Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.5.5 Terumo Recent Development
11.6 BioMerieux
11.6.1 BioMerieux Company Detail
11.6.2 BioMerieux Business Overview
11.6.3 BioMerieux Infectious Disease Point of Care Diagnostics Introduction
11.6.4 BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.6.5 BioMerieux Recent Development
11.7 Diasorin
11.7.1 Diasorin Company Detail
11.7.2 Diasorin Business Overview
11.7.3 Diasorin Infectious Disease Point of Care Diagnostics Introduction
11.7.4 Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.7.5 Diasorin Recent Development
11.8 Roche
11.8.1 Roche Company Detail
11.8.2 Roche Business Overview
11.8.3 Roche Infectious Disease Point of Care Diagnostics Introduction
11.8.4 Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.8.5 Roche Recent Development
11.9 Danaher Corporation
11.9.1 Danaher Corporation Company Detail
11.9.2 Danaher Corporation Business Overview
11.9.3 Danaher Corporation Infectious Disease Point of Care Diagnostics Introduction
11.9.4 Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.9.5 Danaher Corporation Recent Development
11.10 BD
11.10.1 BD Company Detail
11.10.2 BD Business Overview
11.10.3 BD Infectious Disease Point of Care Diagnostics Introduction
11.10.4 BD Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.10.5 BD Recent Development
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Detail
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Introduction
11.11.4 Bio-Rad Laboratories Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.11.5 Bio-Rad Laboratories Recent Development
11.12 Cavidi
11.12.1 Cavidi Company Detail
11.12.2 Cavidi Business Overview
11.12.3 Cavidi Infectious Disease Point of Care Diagnostics Introduction
11.12.4 Cavidi Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.12.5 Cavidi Recent Development
11.13 Cepheid
11.13.1 Cepheid Company Detail
11.13.2 Cepheid Business Overview
11.13.3 Cepheid Infectious Disease Point of Care Diagnostics Introduction
11.13.4 Cepheid Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.13.5 Cepheid Recent Development
11.14 Diaxonhit
11.14.1 Diaxonhit Company Detail
11.14.2 Diaxonhit Business Overview
11.14.3 Diaxonhit Infectious Disease Point of Care Diagnostics Introduction
11.14.4 Diaxonhit Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.14.5 Diaxonhit Recent Development
11.15 Eiken Chemical
11.15.1 Eiken Chemical Company Detail
11.15.2 Eiken Chemical Business Overview
11.15.3 Eiken Chemical Infectious Disease Point of Care Diagnostics Introduction
11.15.4 Eiken Chemical Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.15.5 Eiken Chemical Recent Development
11.16 EMD Millipore
11.16.1 EMD Millipore Company Detail
11.16.2 EMD Millipore Business Overview
11.16.3 EMD Millipore Infectious Disease Point of Care Diagnostics Introduction
11.16.4 EMD Millipore Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.16.5 EMD Millipore Recent Development
11.17 Epitope Diagnostic
11.17.1 Epitope Diagnostic Company Detail
11.17.2 Epitope Diagnostic Business Overview
11.17.3 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Introduction
11.17.4 Epitope Diagnostic Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.17.5 Epitope Diagnostic Recent Development
11.18 Euroimmun
11.18.1 Euroimmun Company Detail
11.18.2 Euroimmun Business Overview
11.18.3 Euroimmun Infectious Disease Point of Care Diagnostics Introduction
11.18.4 Euroimmun Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.18.5 Euroimmun Recent Development
11.19 Gold Standard Diagnostics
11.19.1 Gold Standard Diagnostics Company Detail
11.19.2 Gold Standard Diagnostics Business Overview
11.19.3 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Introduction
11.19.4 Gold Standard Diagnostics Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.19.5 Gold Standard Diagnostics Recent Development
11.20 Hologic
11.20.1 Hologic Company Detail
11.20.2 Hologic Business Overview
11.20.3 Hologic Infectious Disease Point of Care Diagnostics Introduction
11.20.4 Hologic Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.20.5 Hologic Recent Development
11.21 Immunetics
11.21.1 Immunetics Company Detail
11.21.2 Immunetics Business Overview
11.21.3 Immunetics Infectious Disease Point of Care Diagnostics Introduction
11.21.4 Immunetics Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.21.5 Immunetics Recent Development
11.22 InBios International
11.22.1 InBios International Company Detail
11.22.2 InBios International Business Overview
11.22.3 InBios International Infectious Disease Point of Care Diagnostics Introduction
11.22.4 InBios International Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.22.5 InBios International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Abbott
Siemens AG
GE Healthcare
Accriva
Terumo
Biomerieux
DiaSorin
Roche
Danaher Corporation
BD
Bio Rad Laboratories
Cavidi
Cepheid Inc
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
EUROIMMUN
Gold Standard Diagnostics
Hologic Inc
Immunetics
InBios International
List of Tables
    Table 1. Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Over-the-counter (OTC) Testing Kits
    Table 3. Key Players of Prescription-based Testing Kits
    Table 4. Global Infectious Disease Point of Care Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Infectious Disease Point of Care Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Infectious Disease Point of Care Diagnostics Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Infectious Disease Point of Care Diagnostics Market Share by Region (2019-2024)
    Table 8. Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Infectious Disease Point of Care Diagnostics Market Share by Region (2025-2030)
    Table 10. Infectious Disease Point of Care Diagnostics Market Trends
    Table 11. Infectious Disease Point of Care Diagnostics Market Drivers
    Table 12. Infectious Disease Point of Care Diagnostics Market Challenges
    Table 13. Infectious Disease Point of Care Diagnostics Market Restraints
    Table 14. Global Infectious Disease Point of Care Diagnostics Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Infectious Disease Point of Care Diagnostics Market Share by Players (2019-2024)
    Table 16. Global Top Infectious Disease Point of Care Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Point of Care Diagnostics as of 2023)
    Table 17. Ranking of Global Top Infectious Disease Point of Care Diagnostics Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Infectious Disease Point of Care Diagnostics Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Infectious Disease Point of Care Diagnostics Product Solution and Service
    Table 21. Date of Enter into Infectious Disease Point of Care Diagnostics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Infectious Disease Point of Care Diagnostics Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Type (2019-2024)
    Table 25. Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Type (2025-2030)
    Table 27. Global Infectious Disease Point of Care Diagnostics Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Application (2019-2024)
    Table 29. Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Application (2025-2030)
    Table 31. North America Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Infectious Disease Point of Care Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Infectious Disease Point of Care Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Infectious Disease Point of Care Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Infectious Disease Point of Care Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Abbott Company Detail
    Table 47. Abbott Business Overview
    Table 48. Abbott Infectious Disease Point of Care Diagnostics Product
    Table 49. Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
    Table 50. Abbott Recent Development
    Table 51. Siemens Company Detail
    Table 52. Siemens Business Overview
    Table 53. Siemens Infectious Disease Point of Care Diagnostics Product
    Table 54. Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
    Table 55. Siemens Recent Development
    Table 56. GE Healthcare Company Detail
    Table 57. GE Healthcare Business Overview
    Table 58. GE Healthcare Infectious Disease Point of Care Diagnostics Product
    Table 59. GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
    Table 60. GE Healthcare Recent Development
    Table 61. Accriva Company Detail
    Table 62. Accriva Business Overview
    Table 63. Accriva Infectious Disease Point of Care Diagnostics Product
    Table 64. Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
    Table 65. Accriva Recent Development
    Table 66. Terumo Company Detail
    Table 67. Terumo Business Overview
    Table 68. Terumo Infectious Disease Point of Care Diagnostics Product
    Table 69. Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
    Table 70. Terumo Recent Development
    Table 71. BioMerieux Company Detail
    Table 72. BioMerieux Business Overview
    Table 73. BioMerieux Infectious Disease Point of Care Diagnostics Product
    Table 74. BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
    Table 75. BioMerieux Recent Development
    Table 76. Diasorin Company Detail
    Table 77. Diasorin Business Overview
    Table 78. Diasorin Infectious Disease Point of Care Diagnostics Product
    Table 79. Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
    Table 80. Diasorin Recent Development
    Table 81. Roche Company Detail
    Table 82. Roche Business Overview
    Table 83. Roche Infectious Disease Point of Care Diagnostics Product
    Table 84. Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
    Table 85. Roche Recent Development
    Table 86. Danaher Corporation Company Detail
    Table 87. Danaher Corporation Business Overview
    Table 88. Danaher Corporation Infectious Disease Point of Care Diagnostics Product
    Table 89. Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
    Table 90. Danaher Corporation Recent Development
    Table 91. BD Company Detail
    Table 92. BD Business Overview
    Table 93. BD Infectious Disease Point of Care Diagnostics Product
    Table 94. BD Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
    Table 95. BD Recent Development
    Table 96. Bio-Rad Laboratories Company Detail
    Table 97. Bio-Rad Laboratories Business Overview
    Table 98. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Product
    Table 99. Bio-Rad Laboratories Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
    Table 100. Bio-Rad Laboratories Recent Development
    Table 101. Cavidi Company Detail
    Table 102. Cavidi Business Overview
    Table 103. Cavidi Infectious Disease Point of Care Diagnostics Product
    Table 104. Cavidi Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
    Table 105. Cavidi Recent Development
    Table 106. Cepheid Company Detail
    Table 107. Cepheid Business Overview
    Table 108. Cepheid Infectious Disease Point of Care Diagnostics Product
    Table 109. Cepheid Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
    Table 110. Cepheid Recent Development
    Table 111. Diaxonhit Company Detail
    Table 112. Diaxonhit Business Overview
    Table 113. Diaxonhit Infectious Disease Point of Care Diagnostics Product
    Table 114. Diaxonhit Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
    Table 115. Diaxonhit Recent Development
    Table 116. Eiken Chemical Company Detail
    Table 117. Eiken Chemical Business Overview
    Table 118. Eiken Chemical Infectious Disease Point of Care Diagnostics Product
    Table 119. Eiken Chemical Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
    Table 120. Eiken Chemical Recent Development
    Table 121. EMD Millipore Company Detail
    Table 122. EMD Millipore Business Overview
    Table 123. EMD Millipore Infectious Disease Point of Care Diagnostics Product
    Table 124. EMD Millipore Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
    Table 125. EMD Millipore Recent Development
    Table 126. Epitope Diagnostic Company Detail
    Table 127. Epitope Diagnostic Business Overview
    Table 128. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Product
    Table 129. Epitope Diagnostic Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
    Table 130. Epitope Diagnostic Recent Development
    Table 131. Euroimmun Company Detail
    Table 132. Euroimmun Business Overview
    Table 133. Euroimmun Infectious Disease Point of Care Diagnostics Product
    Table 134. Euroimmun Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
    Table 135. Euroimmun Recent Development
    Table 136. Gold Standard Diagnostics Company Detail
    Table 137. Gold Standard Diagnostics Business Overview
    Table 138. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Product
    Table 139. Gold Standard Diagnostics Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
    Table 140. Gold Standard Diagnostics Recent Development
    Table 141. Hologic Company Detail
    Table 142. Hologic Business Overview
    Table 143. Hologic Infectious Disease Point of Care Diagnostics Product
    Table 144. Hologic Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
    Table 145. Hologic Recent Development
    Table 146. Immunetics Company Detail
    Table 147. Immunetics Business Overview
    Table 148. Immunetics Infectious Disease Point of Care Diagnostics Product
    Table 149. Immunetics Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
    Table 150. Immunetics Recent Development
    Table 151. InBios International Company Detail
    Table 152. InBios International Business Overview
    Table 153. InBios International Infectious Disease Point of Care Diagnostics Product
    Table 154. InBios International Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
    Table 155. InBios International Recent Development
    Table 156. Research Programs/Design for This Report
    Table 157. Key Data Information from Secondary Sources
    Table 158. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Infectious Disease Point of Care Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Infectious Disease Point of Care Diagnostics Market Share by Type: 2023 VS 2030
    Figure 3. Over-the-counter (OTC) Testing Kits Features
    Figure 4. Prescription-based Testing Kits Features
    Figure 5. Global Infectious Disease Point of Care Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Infectious Disease Point of Care Diagnostics Market Share by Application: 2023 VS 2030
    Figure 7. Bacterial Infections Case Studies
    Figure 8. Fungal Infection Case Studies
    Figure 9. Virus Infection Case Studies
    Figure 10. Cardiovascular Infection Case Studies
    Figure 11. Gastrointestinal Infection Case Studies
    Figure 12. Sexually Transmitted Disease (STD) Infection Case Studies
    Figure 13. Central Nervous System Infection Case Studies
    Figure 14. Other Case Studies
    Figure 15. Infectious Disease Point of Care Diagnostics Report Years Considered
    Figure 16. Global Infectious Disease Point of Care Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 17. Global Infectious Disease Point of Care Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 18. Global Infectious Disease Point of Care Diagnostics Market Share by Region: 2023 VS 2030
    Figure 19. Global Infectious Disease Point of Care Diagnostics Market Share by Players in 2023
    Figure 20. Global Top Infectious Disease Point of Care Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Point of Care Diagnostics as of 2023)
    Figure 21. The Top 10 and 5 Players Market Share by Infectious Disease Point of Care Diagnostics Revenue in 2023
    Figure 22. North America Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. North America Infectious Disease Point of Care Diagnostics Market Share by Country (2019-2030)
    Figure 24. United States Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe Infectious Disease Point of Care Diagnostics Market Share by Country (2019-2030)
    Figure 28. Germany Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Share by Region (2019-2030)
    Figure 36. China Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Japan Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. South Korea Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. India Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Australia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Latin America Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Latin America Infectious Disease Point of Care Diagnostics Market Share by Country (2019-2030)
    Figure 44. Mexico Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Brazil Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Share by Country (2019-2030)
    Figure 48. Turkey Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Saudi Arabia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Abbott Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
    Figure 51. Siemens Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
    Figure 52. GE Healthcare Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
    Figure 53. Accriva Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
    Figure 54. Terumo Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
    Figure 55. BioMerieux Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
    Figure 56. Diasorin Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
    Figure 57. Roche Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
    Figure 58. Danaher Corporation Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
    Figure 59. BD Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
    Figure 60. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
    Figure 61. Cavidi Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
    Figure 62. Cepheid Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
    Figure 63. Diaxonhit Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
    Figure 64. Eiken Chemical Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
    Figure 65. EMD Millipore Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
    Figure 66. Epitope Diagnostic Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
    Figure 67. Euroimmun Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
    Figure 68. Gold Standard Diagnostics Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
    Figure 69. Hologic Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
    Figure 70. Immunetics Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
    Figure 71. InBios International Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions